Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Works (16)

Data from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.c.6551121
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Data from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.c.6551121.v1
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S1 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546230
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S1 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546230.v1
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S2 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546227
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S2 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546227.v1
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S3 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546224
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S3 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546224.v1
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S4 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546221
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S4 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546221.v1
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S5 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546218
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Figure S5 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546218.v1
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Supplementary Table ST1 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546215
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Supplementary Table ST1 from Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2767-9764.22546215.v1
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer

Cancer Research Communications
2022-12-06 | Journal article
DOI: 10.1158/2767-9764.CRC-22-0158
Contributors: Robert B. Jones; Jonathan Farhi; Miranda Adams; Kiran K. Parwani; Garrett W. Cooper; Milica Zecevic; Richard S. Lee; Andrew L. Hong; Jennifer M. Spangle
Source: check_circle
Crossref

SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities

Cancers
2022-07-27 | Journal article
DOI: 10.3390/cancers14153645
Contributors: Garrett W. Cooper; Andrew L. Hong
Source: check_circle
Crossref
grade
Preferred source (of 2)‎
How many people are using ORCID?